48,460
edits
(more) |
m (→Inflammation) |
||
(14 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
==Prostate biopsy - 4 cores== | |||
===Final=== | |||
1. Prostate, right lateral, biopsy: | |||
- Negative for malignancy. | |||
2. Prostate, right medial, biopsy: | |||
- Negative for malignancy. | |||
3. Prostate, left medial, biopsy: | |||
- Negative for malignancy. | |||
4. Prostate, left lateral, biopsy: | |||
- Negative for malignancy. | |||
==Prostate biopsy - 5 cores== | |||
===Final=== | |||
1. Prostate, right lateral, biopsy: | |||
- Adenocarcinoma, Gleason score 7/10 (3+4); | |||
- 1/1 core involved; approximately 5% of tissue involved. | |||
2. Prostate, right medial, biopsy: | |||
- Adenocarcinoma, Gleason score 7/10 (3+4); | |||
- 1/1 core involved; approximately 40% of tissue involved. | |||
3. Prostate nodule, left transition zone, biopsy: | |||
- Adenocarcinoma, Gleason score 7/10 (3+4); | |||
- 1/1 core involved; approximately 40% of tissue involved. | |||
4. Prostate, left medial, biopsy: | |||
- Negative for malignancy. | |||
5. Prostate, left lateral, biopsy: | |||
- Negative for malignancy. | |||
==Prostate biopsy - 6 cores (apex, mid, base)== | |||
===Final=== | |||
1. Prostate, right apex peripheral, biopsy: | |||
- Benign prostate tissue. | |||
2. Prostate, right mid, biopsy: | |||
- Benign prostatic tissue. | |||
3. Prostate, right base, biopsy: | |||
- Benign prostatic tissue. | |||
4. Prostate, left apex, biopsy: | |||
- Benign prostatic tissue. | |||
5. Prostate, left mid, biopsy: | |||
- Benign prostatic tissue. | |||
6. Prostate, left base, biopsy: | |||
- Benign prostatic tissue. | |||
==Prostate biopsy - 6 cores (base, mid, apex)== | |||
===Final=== | |||
1. Prostate, right base, biopsy: | |||
- Negative for malignancy. | |||
2. Prostate, right mid, biopsy: | |||
- Adenocarcinoma, Gleason score 7/10 (3+4); | |||
- 2/2 cores involved - 1st core: 80% of tissue, 2nd core: 55% of tissue; | |||
- approximately 70% of all tissue involved. | |||
3. Prostate, right apex, biopsy: | |||
- Negative for malignancy. | |||
4. Prostate, left base, biopsy: | |||
- Atypical small acinar proliferation. | |||
5. Prostate, left mid, biopsy: | |||
- Negative for malignancy. | |||
- Acute and chronic inflammation. | |||
6. Prostate, left apex, biopsy: | |||
- Negative for malignancy. | |||
==Prostate biopsy - 7 cores== | |||
===Final=== | |||
1. Prostate, right lateral, biopsy: | |||
- Negative for malignancy. | |||
2. Prostate, right medial, biopsy: | |||
- Negative for malignancy. | |||
- Focal chronic inflammation. | |||
3. Prostate, right transition zone, biopsy: | |||
- Negative for malignancy. | |||
4. Prostate, mid, biopsy: | |||
- Negative for malignancy. | |||
5. Prostate, left transition zone, biopsy: | |||
- Negative for malignancy. | |||
- Focal chronic inflammation. | |||
6. Prostate, left medial, biopsy: | |||
- Negative for malignancy. | |||
7. Prostate, left lateral, biopsy: | |||
- Atypical small acinar proliferation. | |||
==Prostate biopsy - 10 cores== | ==Prostate biopsy - 10 cores== | ||
===Final=== | ===Final=== | ||
Line 75: | Line 178: | ||
12. Prostate, left apex medial, biopsy: | 12. Prostate, left apex medial, biopsy: | ||
- Benign prostate tissue. | - Benign prostate tissue. | ||
==Prostate biopsy - 12 cores - alternate== | |||
===Final=== | |||
<pre> | |||
1. PROSTATE, RIGHT LATERAL SUPERIOR, BIOPSY: | |||
- BENIGN PROSTATE TISSUE. | |||
2. PROSTATE, RIGHT MEDIAL SUPERIOR, BIOPSY: | |||
- BENIGN PROSTATE TISSUE. | |||
3. PROSTATE, RIGHT LATERAL MIDZONE, BIOPSY: | |||
- BENIGN PROSTATE TISSUE. | |||
4. PROSTATE, RIGHT MEDIAL MIDZONE, BIOPSY: | |||
- BENIGN FIBROMUSCULAR TISSUE; | |||
- NO PROSTATIC GLANDULAR TISSUE PRESENT. | |||
5. PROSTATE, RIGHT LATERAL INTERIOR, BIOPSY: | |||
- BENIGN PROSTATE TISSUE. | |||
6. PROSTATE, RIGHT MEDIAL INFERIOR, BIOPSY: | |||
- BENIGN PROSTATE TISSUE. | |||
7. PROSTATE, LEFT LATERAL SUPERIOR, BIOPSY: | |||
- ADENOCARCINOMA, GLEASON SCORE 8/10 (4+4); | |||
- 1/1 CORE INVOLVED; APPROXIMATELY 15% OF TISSUE INVOLVED. | |||
8. PROSTATE, LEFT MEDIAL SUPERIOR, BIOPSY: | |||
- ADENOCARCINOMA, GLEASON SCORE 7/10 (4+3); | |||
- 1/1 CORE INVOLVED; APPROXIMATELY 5% OF TISSUE INVOLVED; | |||
- FOCAL PERINEURAL INVASION PRESENT. | |||
9. PROSTATE, LEFT LATERAL MIDZONE, BIOPSY: | |||
- ADENOCARCINOMA, GLEASON SCORE 8/10 (4+4); | |||
- 1/1 CORE INVOLVED; APPROXIMATELY 50% OF TISSUE INVOLVED. | |||
10. PROSTATE, LEFT MEDIAL MIDZONE, BIOPSY: | |||
- ADENOCARCINOMA, GLEASON SCORE 8/10 (4+4); | |||
- 1/1 CORE INVOLVED; APPROXIMATELY 20% OF TISSUE INVOLVED. | |||
11. PROSTATE, LEFT LATERAL INTERIOR, BIOPSY: | |||
- BENIGN PROSTATE TISSUE. | |||
12. PROSTATE, LEFT MEDIAL INFERIOR, BIOPSY: | |||
- BENIGN PROSTATE TISSUE. | |||
</pre> | |||
== Soft tissue granulomas == | |||
<pre> | |||
J. PROSTATE, LEFT MEDIAL MIDZONE, BIOPSY: | |||
- BENIGN PROSTATE TISSUE; | |||
- FOREIGN BODY-TYPE GRANULOMA, NONNECROTIZING, SEE COMMENT. | |||
COMMENT: | |||
The granulomas appear to be within the periprostatic soft tissue. They consist of | |||
multinucleated (foreign body-type) giant cells, hyaline material and rare interspersed | |||
neutrophils. No necrosis is identified. This finding may represent a reaction to displaced | |||
epithelium from a previous procedure. | |||
</pre> | |||
== Weight == | |||
http://www.ncbi.nlm.nih.gov/pubmed/24053335 | |||
groups: <30, 30-50, >50 | |||
http://www.ncbi.nlm.nih.gov/pubmed/23795788 | |||
volume >80 mL | |||
==Inflammation== | |||
===Micro=== | |||
The sections show prostate cores with marked inflammation, that partially obscures the gland | |||
outlines. The inflammation is predominantly lymphocytic with a lesser amount of | |||
neutrophils and plasma cells. Eosinophils are not readily apparent. An isolated granuloma | |||
without necrosis is seen in one core. | |||
The gland-to-stroma ratio is within normal limits. Basal cells are identified in | |||
the glands. Reactive nuclear changes are present. The gland architecture does not show | |||
changes characteristic of neoplasia. |
edits